Global private equity and venture capital news and research

Posts Tagged ‘Kymab’

20 May 2014

Wellcome Trust, Gates Foundation back UK antibody developer Kymab

UK-based biopharmaceutical business Kymab has picked up $40m through a Series B financing round from the Bill & Melinda Gates Foundation and existing backer the Wellcome Trust.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016